Zimmer Biomet Holdings (ZBH) EBT Margin (2009 - 2026)

Zimmer Biomet Holdings' EBT Margin history runs 18 years deep, the most recent figure standing at 14.44% for Q1 2026.

• On a quarterly basis, EBT Margin rose 244.0% year-over-year to 14.44% in Q1 2026; TTM through Mar 2026 was 0.66%, a 411.0% decrease from a year earlier, with the FY2025 full-year figure at 1.55%, down 483.0% from the prior year.
• EBT Margin rose to 14.44% in Q1 2026 per ZBH's latest filing, from 38.34% in the prior quarter.
• Across five years, EBT Margin topped out at 15.66% in Q1 2023 and bottomed at 38.34% in Q4 2025.
• The 5-year median for EBT Margin is 12.0% (2025), against an average of 7.21%.
• Across the five-year window, EBT Margin surged 4867 bps in 2022 and plunged 3917 bps in 2024, its largest moves.
• Year by year, EBT Margin stood at 9.18% in 2022, then jumped by 60 bps to 14.66% in 2023, then sank by 267 bps to 24.51% in 2024, then plunged by 56 bps to 38.34% in 2025, then soared by 138 bps to 14.44% in 2026.
• Per Business Quant, the three latest ZBH EBT Margin figures stand at 14.44% (Q1 2026), 38.34% (Q4 2025), and 13.95% (Q3 2025).